Main Services
Production of essential oil treatments, FDA-approved nebulizers, Product sales direct to families and hospitals, Subscription services for recurrent purchases, Human clinical trials for product efficacy
MLFD-MedTech Inc., led by Marc DeValera, offers an innovative solution for respiratory virus and bacterial infections using a combination of three all-natural essential oils named XYZENO. This treatment, developed after DeValera's extensive personal use and discovery during the Covid-19 outbreak, provides a non-invasive, no-needle solution. The products work through a Mesh Nebulizer system delivering XYZENO formula directly to the lungs, requiring no refrigeration and are easy to apply. They claim to have proven efficacy through human trials and lab studies, showing a potential to significantly reduce healthcare burdens by preventing and managing respiratory infections effectively. The company emphasizes that their all-natural, easy-to-use treatment could be a breakthrough against respiratory ailments affecting humans.
